Literature DB >> 17085808

Animal models for hypertension/blood pressure recording.

Ralph Plehm1, Marcos E Barbosa, Michael Bader.   

Abstract

Hypertension is an important disease with polygenic inheritance. In order to identify the genes involved in blood pressure regulation, hypertensive rat and mouse models have been developed either by selective breeding or by transgenic technology. The most essential technological prerequisite in these studies is a reliable assessment of the blood pressure in rodents. Three methods are used most frequently for this purpose: tail cuff plethysmography, intra-arterial catheters, and radiotelemetry. Plethysmography is noninvasive, relatively simple, and suitable for a large number of animals, but also imprecise. Intra-arterial catheters are more precise, but require surgery. And both methods restrain and thereby stress the animals, which leads to alterations in blood pressure. Therefore, the telemetric blood pressure measurement, which allows the study of conscious, freely moving animals, has become the gold standard for measuring blood pressure in rodents. However, this method is extremely expensive. Thus, for each experiment the costs have to be put in relation to the quality of data required. This chapter will describe blood pressure measurement methods in technical detail.

Entities:  

Mesh:

Year:  2006        PMID: 17085808     DOI: 10.1385/1-59745-213-0:115

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  12 in total

1.  Knockout of the vascular endothelial glucocorticoid receptor abrogates dexamethasone-induced hypertension.

Authors:  Julie E Goodwin; Junhui Zhang; David Gonzalez; Sebastian Albinsson; David S Geller
Journal:  J Hypertens       Date:  2011-07       Impact factor: 4.844

2.  The glucocorticoid receptor in the distal nephron is not necessary for the development or maintenance of dexamethasone-induced hypertension.

Authors:  Julie E Goodwin; Junhui Zhang; Heino Velazquez; David S Geller
Journal:  Biochem Biophys Res Commun       Date:  2010-02-24       Impact factor: 3.575

3.  Large-conductance Ca2+-activated K+ channel beta1-subunit knockout mice are not hypertensive.

Authors:  Hui Xu; Hannah Garver; James J Galligan; Gregory D Fink
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-03       Impact factor: 4.733

4.  A critical role for vascular smooth muscle in acute glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; Junhui Zhang; David S Geller
Journal:  J Am Soc Nephrol       Date:  2008-04-23       Impact factor: 10.121

Review 5.  Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome.

Authors:  Jonathan M Nizar; Vivek Bhalla
Journal:  Curr Hypertens Rep       Date:  2017-08       Impact factor: 5.369

6.  Sex differences in primary hypertension.

Authors:  Kathryn Sandberg; Hong Ji
Journal:  Biol Sex Differ       Date:  2012-03-14       Impact factor: 5.027

7.  Acute podocyte vascular endothelial growth factor (VEGF-A) knockdown disrupts alphaVbeta3 integrin signaling in the glomerulus.

Authors:  Delma Veron; Guillermo Villegas; Pardeep Kumar Aggarwal; Claudia Bertuccio; Juan Jimenez; Heino Velazquez; Kimberly Reidy; Dale R Abrahamson; Gilbert Moeckel; Michael Kashgarian; Alda Tufro
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

8.  Measurement of invasive blood pressure in rats.

Authors:  Subramani Parasuraman; Ramasamy Raveendran
Journal:  J Pharmacol Pharmacother       Date:  2012-04

9.  The Protective Effects of Sufentanil Pretreatment on Rat Brains under the State of Cardiopulmonary Bypass.

Authors:  Kun Zhang; Man Li; Xiao-Chun Peng; Li-Shen Wang; Ai-Ping Dong; Shu-Wei Shen; Rong Wang
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

10.  Anthrax toxins induce shock in rats by depressed cardiac ventricular function.

Authors:  Linley E Watson; Shu-Ru Kuo; Khurshed Katki; Tongyun Dang; Seong Kyu Park; David E Dostal; Wei-Jen Tang; Stephen H Leppla; Arthur E Frankel
Journal:  PLoS One       Date:  2007-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.